SK Life Science selects Revvity Signals for Laboratory Management
In 2025, SK Life Science, a United States based Life Sciences organization with 350 employees and revenues of $55M selected Revvity Signals for Clinical Trial Management,Laboratory Management while displacing Legacy, and integrating with the existing systems being used.
Customer | Vendor | Old Product | New Product | Category | Market | Users | VAR/SI | When | Live | SK Life Science | Revvity | Legacy | Revvity Signals | Clinical Trial Management,Laboratory Management | ERP Services and Operations | n/a | n/a | 2025 | 2025 |
---|
Discover the latest software purchases and digital transformation initiatives being undertaken by SK Life Science and its business and technology executives by accessing the entire SK Life Science and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by SK Life Science employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.
Don't miss the entire: SK Life Science Technographics profile